Health effects of olive oil polyphenols: Recent advances and possibilities for the use of health claims

Molecular Nutrition and Food Research

Volumn 57, Issue 5, 2013, Pages 760-771

  Martín Peláez, Sandra ^a   Covas, María Isabel ^a,b   Fitó, Montserrat ^a,b   Kušar, Anita ^c   Pravst, Igor ^c  

^a Program on Research on Inflammatory and Cardiovascular Disorders (RICAD)   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Nutrition Institute   (Slovenia)

Author keywords

Health; Health claims; Labelling; Olive Oil; Polyphenols

Indexed keywords

ANTIINFLAMMATORY AGENT; OLEIC ACID; OLIVE OIL; POLYPHENOL; VEGETABLE OIL;

CARDIOVASCULAR DISEASE; CHEMISTRY; CHRONIC DISEASE; DRUG EFFECT; HUMAN; INFLAMMATION; MEDITERRANEAN DIET; MICROFLORA; NEOPLASM; NUTRIGENOMICS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR;

ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIET, MEDITERRANEAN; HUMANS; INFLAMMATION; MICROBIOTA; NEOPLASMS; NUTRIGENOMICS; OLEIC ACID; OXIDATIVE STRESS; PLANT OILS; POLYPHENOLS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84876436315     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200421     Document Type: Review

References (164)

1. Tunstall-Pedoe, H., Kuulasmaa, K., Mahonen, M., Tolonen, H. et al., Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999, 353, 1547-1557.
2. Keys, A., Arabanis, C., Blackburn, H., Buzina, R. et al., Seven Countries: A Multivariate Analysis of Death And Coronary Heart Disease, Harvard University Press, Cambridge, MA and London 1980, pp. 1-381.
3. De Lorgeril, M., Salen, P., Martin, J. L., Monjaud, I. et al., Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99, 779-785.
4. Trichopoulou, A., Costacou, T., Bamia, C., Trichopoulos, D., Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 2003, 348, 2599-2608.
5. Scarmeas, N., Stern, Y., Tang, M. X., Mayeux, R. et al., Mediterranean diet and risk for Alzheimer's disease. Ann. Neurol. 2006, 59, 912-921.
6. Benetou, V., Trichopoulou, A., Orfanos, P., Naska, A. et al., Greek EPIC cohort. Conformity to traditional Mediterranean diet and cancer incidence: the Greek EPIC cohort. Br. J. Cancer 2008, 99, 191-195.
7. Sofi, F., Cesari, F., Abbate, R., Gensini, G. F. et al., Adherence to Mediterranean diet and health status: meta-analysis. Br. Med. J. 2008, 337, a1334.
8. Urpi-Sarda, M., Casas, R., Chiva-Blanch, G., Romero-Mamani, E. S. et al., Virgin olive oil and nuts as key foods of the Mediterranean diet effects on inflammatory biomarkers related to atherosclerosis. Pharmacolog. Res. 2012, 65, 577-583.
9. DG Agriculture & Rural Development. Agricultural Markets Briefs. Prospects for the olive oil sector in Spain, Italy and Greece 2012-2020. Brief No. 2, 2012, http://ec.europa.eu/agriculture/analysis/markets/index_en.htm; accessed: December 2012.
10. Quiles, J. L., Ramirez-Tortosa, M. C., Yaqoob, P., Olive Oil and Health, CABI Publishing, Oxford 2006.
11. Granados-Principal, S., Quiles, J. L., Ramirez-Tortosa, C. L., Sanchez-Rovira, P. et al., Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr. Rev. 2010, 68, 191-206.
12. Omar, S. H., Oleuropein in olive and its pharmacological effects. Sci. Pharm. 2010, 78, 133-154.
13. Karihtala, P., Soini, Y., Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. Apmis 2007, 115, 81-103.
14. Li, L., Ishdorj, G., Gibson, S. B., Reactive oxygen species regulation of autophagy in cancer: implications for cancer treatment. Free Radic. Biol. Med. 2012, 53, 1399-1410.
15. Lonn, M. E., Dennis, J. M., Stocker, R., Actions of antioxidants in the protection against atherosclerosis. Free Radic. Biol. Med. 2012, 53, 863-884.
16. Wang, J. C., Bennett, M., Aging and atherosclerosis. Circ. Res. 2012, 111, 245-259.
17. Muzzalupo, I., Stefanizzi, F., Perri, E., Chiappetta, A., Transcript levels of CHL P gene, antioxidants and chlorophylls contents in olive olea europaea pericarps: a comparative study on eleven olive cultivars harvested in two ripening stages. Plant Foods Hum. Nutr. 2011, 66, 1-10.
18. Visioli, F., Galli, C., The effect of minor constituents of olive oil on cardiovascular disease: new findings. Nutr. Rev. 1998, 56, 142-147.
19. Corona, G., Spencer, J. P. E., Dessi, M. A., Extra virgin olive oil phenolics: absorption, metabolism, and biological activities in the GI tract. Toxicol. Ind. Health 2009, 25, 285-293.
20. Cicerale, S., Conlan, X. A., Sinclair, A. J., Keast, R. S. J., Chemistry and health of olive oil phenolics. Crit. Rev. Food Sci. Nutr. 2009, 49, 218-236.
21. Amarowicz, R., Carle, R., Dongowski, G., Durazzo, A. et al., Influence of postharvest processing and storage on the content of phenolic acids and flavonoids in foods. Mol. Nutr. Food Res. 2009, 53, S151-S183.
22. Owen, R. W., Mier, W., Giacosa, A., Hull, W. E. et al., Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignans and squalene. Food Chem. Toxicol. 2000, 38, 647-659.
23. Esti, M., Cinquanta, L., La Notte, E., Phenolic compounds in different olive varieties. J. Agric. Food Chem. 1998, 46, 32-35.
24. Garcia, A., Brenes, M., Romero, C., Garcia, P. et al., Study of phenolic compounds in virgin olive oils of the Picual variety. Eur. Food Res. Technol. 2002, 215, 407-412.
25. Oliveras-Lopez, M. J., Innocenti, M., Giaccherini, C., Ieri, F. et al., Study of the phenolic composition of Spanish and Italian monocultivar extra virgin olive oils: distribution of lignans, secoiridoidic, simple phenols and flavonoids. Talanta 2007, 73, 726-732.
26. Andjelkovic, M., Van Camp, J., Pedra, M., Renders, K. et al. Correlations of the phenolic compounds and the phenolic content in some Spanish and French olive oils. J. Agric. Food Chem. 2008, 56, 5181-5187.
27. Bester, E., Butinar, B., Bucar-Miklavcic, M., Golob, T., Chemical changes in extra virgin olive oils from Slovenian Istra after thermal treatment. Food Chem. 2008, 108, 446-454.
28. Vissers, M. N., Zock, P. L., Katan, M. B., Bioavailability and antioxidant effects of olive oil phenols in humans: a review. Eur. J. Clin. Nutr. 2004, 58, 955-965.
29. Owen, W. R., Giacosa, A., Hull, W. E., Haubner, R. et al., Olive-oil consumption and health: the possible role of antioxidants. Lancet Oncol. 2000, 1, 107-112.
30. Visioli, F., Galli, C., Biological properties of olive oil phytochemicals. Crit. Rev. Food Sci. Nutr. 2002, 42, 209-221.
31. Tuck, K. L., Hayball, P. J., Major phenolic compounds in olive oil: metabolism and health effects. J. Nutr. Biochem. 2002, 13, 636-644.
32. Tripoli, E., Giammanco, M., Tabacchi, G., Di Majo, D. et al., The phenolic compounds of olive oil: structure, biological activity and beneficial effects on human health. Nutr. Res. Rev. 2005, 18, 98-112.
33. Bendini, A., Cerretani, L., Carrasco-Pancorbo, A., Gomez-Caravaca, A. M. et al., Phenolic molecules in virgin olive oils: a survey of their sensory properties, health effects, antioxidant activity and analytical methods. An overview of the last decade. Molecules 2007, 12, 1679-1719.
34. Waterman, E., Lockwood, B., Active componenets and clinical applications of olive oil. Altern. Med. Rev. 2007, 12, 331-342.
35. Carluccioll, M. A., Massaro, M., Scoditti, E., De Caterina, R., Vasculoprotective potential of olive oil components. Mol. Nutr. Food Res. 2007, 51, 1225-1234.
36. Fito, M., de la Torre, R., Covas, M. I., Olive oil and oxidative stress. Mol. Nutr. Food Res. 2007, 51, 1215-1224.
37. Perez-Jimenez, F., Ruano, J., Perez-Martinez, P., Lopez-Segura, F. et al., The influence of olive oil on human health: not a question of fat alone. Mol. Nutr. Food Res. 2007, 51, 1199-1208.
38. Bach-Faig, A., Fuentes-Bol, C., Ramos, D., Carrasco, J. L. et al., The Mediterranean diet in Spain: adherence trends during the past two decades using the Mediterranean Adequacy Index. Public Health Nutr. 2011, 14, 622-628.
39. Oubina, P., Sanchez-Muniz, F. J., Rodenas, S., Cuesta, C., Eicosanoid production, thrombogenic ratio, and serum and LDL peroxides in normo- and hypercholesterolaemic post-menopausal women consuming two oleic acid-rich diets with different content of minor components. Brit. J. Nutr. 2001, 85, 41-47.
40. Vissers, M. N., Zock, P. L., Wiseman, S. A., Meyboom, S. et al., Effect of phenol-rich extra virgin olive oil on markers of oxidation in healthy volunteers. Eur. J. Clin. Nutr. 2001, 55, 334-341.
41. Vissers, M. N., Zock, P. L., Roodenburg, A. J. C., Leenen, R. et al., Olive oil phenols are absorbed in humans. J. Nutr. 2002, 132, 409-417.
42. Moschandreas, J., Vissers, M. N., Wiseman, S., van Putte, K. P. et al., Extra virgin olive oil phenols and markers of oxidation in Greek smokers: a randomized cross-over study. Eur. J. Clin. Nutr. 2002, 56, 1024-1029.
43. Acin, S., Navarro, M. A., Arbones-Mainar, J. M., Guillen, N. et al., Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient mice. J. Biochem. (Tokyo) 2006, 140, 383-391.
44. Raederstorff, D., Antioxidant activity of olive polyphenols in humans: a review. Int. J. Vitam. Nutr. Res. 2009, 79, 152-165.
45. Kleczkowski, M., Garncarz, M., The role of metal ions in biological oxidation-the past and the present. Pol. J. Vet. Sci. 2012, 15, 165-173.
46. Sies, H., Oxidative stress: oxidants and antioxidants. Exp. Physiol. 1997, 82, 291-295.
47. Valko, M., Morris, H., Cronin, M. T. D., Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12, 1161-1208.
48. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D. et al., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44-84.
49. Lopez-Miranda, J., Perez-Jimenez, F., Ros, E., De Caterina, R. et al., Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 284-294.
50. Beauchamp, G. K., Keast, R. S., Morel, D., Lin, J. et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 2005, 437, 45e6.
51. Perez-Herrera, A., Delgado-Lista, J., Torres-Sanchez, L. A., Rangel-Zuniga, O. A. et al., The postprandial inflammatory response after ingestion of heated oils in obese persons is reduced by the presence of phenol compounds. Mol. Nutr. Food Res. 2012, 56, 510-514.
52. Pizza, V., Agresta, A., DA, W., Festa, M. et al., Neuroinflammation and ageing: current theories and an overview of the data. Rev. Recent Clin. Trials 2011, 6, 189-203.
53. Tousoulis, D., Kampoli, A. M., Papageorgiou, N., Androulakis, E. et al., Pathophysiology of atherosclerosis: the role of inflammation. Curr. Pharm. Des. 2011, 17, 4089-4110.
54. Witztum, J. L., The oxidation hypothesis of atherosclerosis. Lancet 1994, 344, 793-795.
55. Moore, K. J., Tabas, I., Macrophages in the pathogenesis of atherosclerosis. Cell 2011, 145, 341-355.
56. Berrougui, H., Guillaume, G., Soumaya, L., Genevieve, D. et al., A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux. Atherosclerosis 2009, 207, 420-427.
57. Mitra, S., Deshmukh, A., Sachdeva, R., Lu, J. J. et al., Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am. J. Med. Sci. 2011, 342, 135-142.
58. Covas, M. I., de la Torre, K., Farre-Albaladejo, M., Kaikkonen, J. et al., Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic. Biol. Med. 2006, 40, 608-616.
59. Nicolaiew, N., Lemort, N., Adorni, L., Berra, B. et al., Comparison between extra virgin olive oil and oleic acid rich sunflower oil: effects on postprandial lipemia and LDL susceptibility to oxidation. Ann. Nutr. Metab. 1998, 42, 251-260.
60. Ramirez-Tortosa, M. C., Urbano, G., Lopez-Jurado, M., Nestares, T. et al., Extra-virgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease. J. Nutr. 1999, 129, 2177-2183.
61. Weinbrenner, T., Fito, M., de la Torre, R., Saez, G. T. et al., Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men. J. Nutr. 2004, 134, 2314-2321.
62. Marrugat, J., Covas, M. I., Fito, M., Schroder, H. et al., Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation-A randomized controlled trial. Eur. J. Nutr. 2004, 43, 140-147.
63. Covas, M. I., Nyyssonen, K., Poulsen, H. E., Kaikkonen, J. et al., The effect of polyphenols in olive oil on heart disease risk factors-A randomized trial. Ann. Intern. Med. 2006, 145, 333-341.
64. Vazquez-Velasco, M., Diaz, L. E., Lucas, R., Gomez-Martinez, S. et al., Effects of hydroxytyrosol-enriched sunflower oil consumption on CVD risk factors. Brit. J. Nutr. 2011, 105, 1448-1452.
65. Fito, M., Cladellasc, M., de la Torre, R., Marti, J. et al., Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis 2005, 181, 149-158.
66. EFSA NDA Panel, Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage. EFSA J. 2011, 9, 2033, doi:10.2903/j.efsa.2011.2033.
67. Castaner, O., Fitó, M., López-Sabater, M. C., Poulsen, H. E. et al., EUROLIVE Study Group. The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. Clin. Nutr. 2011, 30, 490-493.
68. Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M. et al., Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 2007, 357, 2109-2122.
69. EFSA NDA Panel, Scientific Opinion on the substantiation of a health claim related to polyphenols in olive and maintenance of normal blood HDL cholesterol concentrations (ID 1639, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2012, 10, 2848, doi:10.2903/j.efsa.2012.2848.
70. Besler, C., Luscher, T. F., Landmesser, U., Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease. Embo. Molec. Med. 2012, 4, 251-268.
71. Rye, K. A., Bursill, C. A., Lambert, G., Tabet, F. et al., The metabolism and anti-atherogenic properties of HDL. J. Lipid Res. 2009, 50, S195-S200.
72. de la Llera-Moya, M., Drazul-Schrader, D., Asztalos, B. F., Cuchel, M. et al., The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 796-801.
73. Linsel-Nitschke, P., Tall, A. R., HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat. Rev. Drug Discov. 2005, 4, 193-205.
74. Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A. et al., Cholesterol efflux and atheroprotection advancing the concept of reverse cholesterol transport. Circulation 2012, 125, 1905-1919.
75. Tall, A. R., The effects of cholesterol ester transfer protein inhibition on cholesterol efflux. Am. J. Cardiol. 2009, 104, 39E-45E.
76. Luo, D. X., Cao, D. L., Xiong, Y., Peng, X. H. et al., A novel model of cholesterol efflux from lipid-loaded cells. Acta. Pharmacol. Sin. 2010, 31, 1243-1257.
77. Rifici, V. A., Khachadurian, A. K., Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim. Biophys. Acta. Lipids Lipid Metab. 1996, 1299, 87-94.
78. Shao, B., Heinecke, J. W., Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway. J. Proteomics 2011, 74, 2289-2299.
79. Shao, B., Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. Biochim. Biophys. Acta: Proteins Proteomics 2012, 1821, 490-501.
80. Ruano, J., Lopez-Miranda, J., Fuentes, F., Moreno, J. A. et al., Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J. Am. Coll. Cardiol. 2005, 46, 1864-1868.
81. Widmer, R., Freund, M., Flammer, A., Sexton, J. et al., Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis. Eur. J. Nutr. 2012, doi 10.1007/s00394-012-0433-2.
82. Moreno-Luna, R., Munoz-Hernandez, R., Miranda, M. L., Costa, A. F. et al., Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Am. J. Hypertens. 2012, 25, 1229-1304.
83. Zrelli, H., Matsuka, M., Araki, M., Zarrouk, M. et al., Hydroxytyrosol induces vascular smooth muscle cells apoptosis through NO production and PP2A activation with subsequent inactivation of Akt. Planta Medica. 2011, 77, 1680-1686.
84. Zrelli, H., Matsuoka, M., Kitazaki, S., Zarrouk, M. et al., Hydroxytyrosol reduces intracellular reactive oxygen species levels in vascular endothelial cells by upregulating catalase expression through the AMPK-FOXO3a pathway. Eur. J. Pharmacol. 2011, 660, 275-282.
85. Zrelli, H., Matsuoka, M., Kitazaki, S., Araki, M. et al., Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J. Agric. Food Chem. 2011, 59, 4473-4482.
86. Deiana, M., Incani, A., Rosa, A., Atzeri, A. et al., Hydroxytyrosol glucuronides protect renal tubular epithelial cells against H(2)O(2) induced oxidative damage. Chem. Biol. Interact. 2011, 193, 232-239.
87. Victor, V. M., Rocha, M., Sola, E., Banuls, C. et al., Oxidative stress, endothelial dysfunction and atherosclerosis. Curr. Pharm. Des. 2009, 15, 2988-3002.
88. Petroni, A., Blasevich, M., Salami, M., Papini, N. et al., Inhibition of platelet-aggregation and eicosanoid production by phenolic components of olive oil. Thromb. Res. 1995, 78, 151-160.
89. Gonzalez-Correa, J. A., Navas, M. D., Munoz-Marin, J., Trujillo, M. et al., Effects of hydroxytyrosol and hydroxytyrosol acetate administration to rats on platelet function compared to acetylsalicylic acid. J. Agric. Food Chem. 2008, 56, 7872-7876.
90. Bogani, P., Galli, C., Villa, M., Visioli, F., Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 2007, 190, 181-186.
91. Visioli, F., Caruso, D., Grande, S., Bosisio, R. et al., Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur. J. Nutr. 2005, 44, 121-127.
92. Ruano, J., Lopez-Miranda, J., de la Torre, R., Delgado-Lista, J. et al., Intake of phenol-rich virgin olive oil improves the postprandial prothrombotic profile in hypercholesterolemic patients. Am. J. Clin. Nutr. 2007, 86, 341-346.
93. Abe, R., Beckett, J., Abe, R., Nixon, A. et al. Olive oil polyphenol oleuropein inhibits smooth muscle cell proliferation. Eur. J. Vasc. Endovasc. Surg. 2011, 41, 814-820.
94. Lavecchia, C., Negri, E., Franceschi, S., Decarli, A. et al., Olive oil, other dietary fats, and the risk of breast cancer (Italy). Cancer Causes Contr. 1995, 6, 545-550.
95. Brinkman, M. T., Buntinx, F., Kellen, E., Van Dongen, M. C. et al., Consumption of animal products, olive oil and dietary fat and results from the Belgian case-control study on bladder cancer risk. Eur. J. Cancer 2011, 47, 436-442.
96. Pelucchi, C., Bosetti, C., Negri, E., Lipworth, L. et al., Olive oil and cancer risk: an update of epidemiological findings through 2010. Curr. Pharm. Des. 2011, 17, 805-812.
97. Psaltopoulou, T., Kosti, R., Haidopoulos, D., Dimopoulos, M. et al., Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13, 800 patients and 23, 340 controls in 19 observational studies. Lip. Health Dis. 2011, 10, 127.
98. Salvini, S., Sera, F., Caruso, D., Giovannelli, L. et al., Daily consumption of a high-phenol extra-virgin olive oil reduces oxidative DNA damage in postmenopausal women. Brit. J. Nutr. 2006, 95, 742-751.
99. Quiles, J. L., Farquharson, A. J., Simpson, D. K., Grant, I. et al., Olive oil phenolics: effects on DNA oxidation and redox enzyme mRNA in prostate cells. Brit. J. Nutr. 2002, 88, 225-234.
100. Ilavarasi, K., Kiruthiga, P. V., Pandian, S. K., Devi, K. P., Hydroxytyrosol, the phenolic compound of olive oil protects human PBMC against oxidative stress and DNA damage mediated by 2, 3, 7, 8-TCDD. Chemosphere 2011, 84, 888-893.
101. Fabiani, R., De Bartolomeo, A., Rosignoli, P., Servili, M. et al., Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G(1) cell cycle arrest and apoptosis. Eur. J. Cancer Prev. 2002, 11, 351-358.
102. Corona, G., Deiana, M., Incani, A., Vauzour, D. et al., Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem. Biophys. Res. Commun. 2007, 362, 606-611.
103. Corona, G., Deiana, M., Incani, A., Vauzour, D. et al., Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1. Mol. Nutr. Food Res. 2009, 53, 897-903.
104. Scoditti, E., Calabriso, N., Massaro, M., Pellegrino, M. et al., Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch. Biochem. Biophys. 2012, 527, 81-89.
105. Notas, G., Pelekanou, V., Castanas, E., Kampa, M., in: Boskou, D. (Ed.), Olive Oil: Minor Constituents and Health. CRC Press, Boca Raton, FL 2008, pp. 129-171.
106. Harman, D. J., Aging: a theory based on free radical and radiation chemistry. Gerontology 1956, 11, 298-300.
107. Farr, S. A., Price, T. O., Dominguez, L. J., Motisi, A. et al., Extra virgin olive oil improves learning and memory in SAMP8 mice. J. Alzheim. Dis. 2012, 28, 81-92.
108. St-Laurent-Thibault, C., Arseneault, M., Longpre, F., Ramassamy, C., Tyrosol and hydroxytyrosol two main components of olive oil, protect N2a cells against amyloid-beta-induced toxicity. Involvement of the NF-kappa B signaling. Curr. Alzh. Res. 2011, 8, 543-551.
109. Schraen-Maschke, S., Sergeant, N., Dhaenens, C. M., Bombois, S. et al., Tau as a biomarker of neurodegenerative diseases. Biomarkers Med. 2008, 2, 363-384.
110. Ballatore, C., Lee, V. M., Trojanowski, J. Q., Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8, 663-672.
111. Daccache, A., Lion, C., Sibille, N., Gerard, M. et al., Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochem. Int. 2011, 58, 700-707.
112. Zhu, L., Liu, Z. B., Feng, Z. H., Hao, J. J. et al., Hydroxytyrosol protects against oxidative damage by simultaneous activation of mitochondrial biogenesis and phase II detoxifying enzyme systems in retinal pigment epithelial cells. J. Nutr. Biochem. 2010, 21, 1089-1098.
113. Impellizzeri, D., Esposito, E., Mazzon, E., Paterniti, I. et al., Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. J. Pharmacol. Exp. Ther. 2011, 339, 859-869.
114. Impellizzeri, D., Esposito, E., Mazzon, E., Paterniti, I. et al., The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy. Clin. Nutr. 2011, 30, 533-540.
115. Corona, G., Tzounis, X., Assunta Dessi, M., Deiana, M. et al., The fate of olive oil polyphenols in the gastrointestinal tract: implications of gastric and colonic microflora-dependent biotransformation. Free Radic. Res. 2006, 40, 647-658.
116. Caesar, R., Fak, F., Bäckhed, F., Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J. Intern. Med. 2010, 268, 320-328.
117. Landete, J. M., Cruiel, J. A., Rodríguez, H., de las Rivas, B. et al., Study of the inhibitory activity of phenolic compounds found in olive products and their degradation by Lactobacillus plantarum strains. Food Chem. 2008, 107, 320-326.
118. Vernazza, C. L., Rabiu, B. A., Gibson, G. R., in: Gibson, G. R., Rastall, R. A. (Eds.), Prebiotics: Development & Application, John Wiley & Sons Ltd., England 2006, 1-12.
119. Martinez, I., Wallace, G., Zhang, C. M., Legge, R. et al., Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl. Environ. Microbiol. 2009, 75, 4175-4184.
120. Christianes, H., Leer, R. J., Pouwels, P. H., Verstraete, W., Cloning and expression of a conjugated bile acid hydrolase gene from Lactobacillus plantarum by using a direct plate assay. Appl. Envir. Microbiol. 1992, 58, 3792-3798.
121. De Rodas, B. Z., Gilliland, S. E., Maxwell, C. V., Hypocholesterolemic action of Lactobacillus acidophilus ATCC 43121 and calcium in swine with hypercholesterolemia induced by diet. J. Dairy Sci. 1996, 79, 2121-2128.
122. De Smet, I., Van Hoorde, L., De Saeyer, N., Vande Woestyne, M. et al., In vitro study of bile salt hydrolase (BSH) activity of BSH isogenic Lactobacillus plantarum 80 strains and estimation of cholesterol lowering through enhanced BSH activity. Microb. Ecol. Health Dis. 1994, 7, 315-329.
123. Brown, M. S., Goldstein, J. L., Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 1983, 52, 223-261.
124. Pigeon, R. M., Cuesta, E. P., Gilliland, S. E., Binding of free bile acids by cells of yoghurt starter culture bacteria. J. Dairy Sci. 2002, 85, 2705-2710.
125. Liong, M. T., Shah, N. P., Acid and bile tolerance and the cholesterol removal ability of lactobacilli strains. J. Dairy Sci. 2005, 88, 55-66.
126. Fukushima, M., Nakano, M., Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on cholesterol metabolism in rats fed on a fat- and cholesterol-enriched diet. Brit. J. Nutr. 1996, 76, 857-867.
127. Cheeke, P. R., Actual and potential applications of Yucca schidigera and Quillaja saponaria saponins in human and animal nutrition. J. Anim. Sci. 2000, 77, 1-10.
128. Leahy, S. C., Higgins, D. G., Fitzgerald, G. F., van Sinderen, D., Getting better with bifidobacteria. J. Appl. Microbiol. 2005, 98, 1303-1315.
129. Karlsson, C., Ahrne, S., Molin, G., Berggren, A. et al., Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial diversity in colon: a randomized controlled trial. Atherosclerosis 2010, 208, 228-233.
130. De la Torre-Carbot, K., Chávez-Servín, J. L., Jaúregui, O., Castellote, A. I. et al., Presence of virgin olive oil phenolic metabolites in human low density lipoprotein fraction: determination by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Chim. Acta 2007, 583, 402-410.
131. St-Onge, M. P., Farnworth, E. R., Jones, P. J. H., Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. Am. J. Clin. Nutr. 2000, 71, 674-681.
132. Wolever, T. M. S., Spadafora, P., Eshuis, H., Interaction between colonic acetate and propionate in humans. Am. J. Clin. Nutr. 1991, 53, 681-687.
133. Wolever, T. M., Fernandes, J., Rao, A. V., Serum acetate:propionate ratio is related to serum cholesterol in men but not women. J. Nutr. 1996, 126, 2790-2797.
134. Trautwein, E. A., Rieckhoff, D., Erbersdobler, H. F., Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamster. J. Nutr. 1998, 128, 1937-1943.
135. Medina, E., Brenes, M., Romero, C., Garcia, A. et al., Main antimicrobial compounds in table olives. J. Agric. Food Chem. 2007, 55, 9817-9823.
136. Romero, C., Medina, E., Vargas, J., Brenes, M. et al., In vitro activity of olive oil polyphenols against Helicobacter pylori. J. Agric. Food Chem. 2007, 55, 680-686.
137. Bisignano, G., Tomaino, A., Lo Cascio, R., Crisafi, G. et al., On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. J. Pharm. Pharmacol. 1999, 51, 971-974.
138. Furneri, P. M., Piperno, A., Sajia, A., Bisignano, G., Antimycoplasmal activity of hydroxytyrosol. Antimicrob. Agents Chemother. 2004, 48, 4892-4894.
139. Medina, E., De Castro, A., Romero, C., Brenes, M., Comparison of the concentrations of phenolic compounds in olive oils and other plant oils: correlation with antimicrobial activity. J. Agric. Food Chem. 2006, 54, 4954-4961.
140. Fredrickson, W. R., Method and composition for antiviral therapy, F&S Group, Inc., 2000, US Patent 6, 455, 580.
141. Ma, S. C., He, Z. D., Deng, X. L., But, P. P. H. et al., In vitro evaluation of secoiridoid glucosides from the fruits of Ligustrum lucidum as antiviral agents. Chem. Pharm. Bull. (Tokyo) 2001, 49, 1471-1473.
142. Koren, O., Spor, A., Felin, J., Fak, F. et al., Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl. Acad. Sci. USA 2011, 108, 4592-4598.
143. Konstantinidou, V., Covas, M. I., Munoz-Aguayo, D., Khymenets, O. et al. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. Faseb. J. 2010, 24, 2546-2557.
144. Camargo, A., Ruano, J., Fernandez, J. M., Parnell, L. D. et al., Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genom. 2010, 11, 253, doi:10.1186/1471-2164-11-253.
145. Bouallagui, Z., Han, J., Isoda, H., Sayadi, S., Hydroxytyrosol rich extract from olive leaves modulates cell cycle progression in MCF-7 human breast cancer cells. Food Chem. Toxicol. 2011, 49, 179-184.
146. Granados-Principal, S., Quiles, J. L., Ramirez-Tortosa, C., Camacho-Corencia, P. et al., Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours. Mol. Nutr. Food Res. 2011, 55, S117-S126.
147. Warnke, I., Goralczyk, R., Fuhrer, E., Schwager, J., Dietary constituents reduce lipid accumulation in murine C3H10 T1/2 adipocytes: a novel fluorescent method to quantify fat droplets. Nutr. Metab. 2011, 8, 30, doi:10.1186/1743-7075-8-30.
148. Drira, R., Chen, S., Sakamoto, K., Oleuropein and hydroxytyrosol inhibit adipocyte differentiation in 3 T3-L1 cells. Life Sci. 2011, 89, 708-716.
149. Cotrim, B. A., Joglar, J., Rojas, M. J. L., del Olmo, J. M. D. et al., Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties. J. Agric. Food Chem. 2012, 60, 1067-1074.
150. Razquin, C., Martinez, J. A., Martinez-Gonzalez, M. A., Fernandez-Crehuet, J. et al., A Mediterranean diet rich in virgin olive oil may reverse the effects of the-174G/C IL6 gene variant on 3-year body weight change. Mol. Nutr. Food Res. 2010, 54, S75-S82.
151. Santiago-Mora, R., Casado-Diaz, A., De Castro, M. D., Quesada-Gomez, J. M., Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow. Osteoporos. Int. 2011, 22, 675-684.
152. Duque, G., Bone and fat connection in aging bone. Curr. Opin. Rheumatol. 2008, 20, 429-434.
153. Hagiwara, K., Goto, T., Araki, M., Miyazaki, H. et al., Olive polyphenol hydroxytyrosol prevents bone loss. Eur. J. Pharmacol. 2011, 662, 78-84.
154. Sánchez-Fidalgo, S., Sánchez de Ibargüen, L., Cárdeno, A., Alarcón de la Lastra, C., Influence of extra virgin olive oil diet enriched with hydroxytyrosol in a chronic DSS colitis model. Eur. J. Nutr. 2012, 51, 497-506.
155. Pothoulaki, M., Chryssochoidis, G., Health claims: Consumers' matters. J. Funct. Foods 2009, 1, 222-228.
156. Mariotti, F., Kalonji, E., Huneau, J. F., Margaritis, I., Potential pitfalls of health claims from a public health nutrition perspective. Nutr. Rev. 2010, 68, 624-638.
157. Cappuccio, F. P., Pravst, I., Health claims on foods: promoting healthy food choices or high salt intake? Brit. J. Nutr. 2011, 106, 1770-1771.
158. Pravst, I., The evaluation of health claims in Europe: What have we learned? Agro. Food Ind. Hi-Tech 2010, 21, 4-6.
159. Pravst, I., Risking public health by approving some health claims?-The case of phosphorus. Food Policy 2011, 36, 725-727.
160. Pravst, I., Health claims: where are we now and where are we going? Agro Food Ind. Hi-Tech 2011, 22, 2-3.
161. Pravst, I., in: Valdez, B. (Ed.), Scientific, Health and Social Aspects of the Food Industry, InTech, Rijeka, 2012.
162. EFSA NDA Panel, Scientific Opinion on the substantiation of health claims related to vitamin E and protection of DNA, proteins and lipids from oxidative damage. EFSA J. 2010, 8, 1816, doi:10.2903/j.efsa.2010.1869.
163. EFSA NDA Panel, Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL cholesterol concentrations. EFSA J. 2011, 9, 2069.
164. Trichopoulou, A., Dilis, V., Olive oil and longevity. Mol. Nutr. Food Res. 2007, 51, 1275-1278.